A clinical trial for the evaluation of the efficacy and safety of kestose on atopic dermatitis in childre
Not Applicable
Recruiting
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0003876
- Lead Sponsor
- Samyang
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
1)subject who signs Informed Consent Form with a legal representative who signs the informed consent form before participating in the study
2)subject aged between 1 years and 11 years with atopic dermatitis
3)subject with intermittent or continuous atopic dermatits symptom over 6 months
4)subject with SCORing of Atopic Dermatitis index between 25 and 50 (moderate)
Exclusion Criteria
1)subject with other systemic illnesses or dermatits history except Atopic Dermatitis
2)subject administrating immunosuppressant,antobiotics,corticosteroid, antihistaminic within 4 weeks
3)subject who has taken medicines,chinese medicine, health functional foods within 4 weeks for improvement of atopic dermatiti
4) subject who has treatened phototherapy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORing of Atopic Dermatitis score (SCORAD)
- Secondary Outcome Measures
Name Time Method SCORing of Atopic Dermatitis score (SCORAD) subjective score;SCORing of Atopic Dermatitis score (SCORAD) objective score;Investigator’s Global Assessment;Eosinophil count;IFN-?, IL-4, IL-10, IL-13;SCFA(short chain fatty acid) in stools;total IgE